TY  - GEN
AU  - Amlot,P L
AU  - Stone,M J
AU  - Cunningham,D
AU  - Fay,J
AU  - Newman,J
AU  - Collins,R
AU  - May,R
AU  - McCarthy,M
AU  - Richardson,J
AU  - Ghetie,V
TI  - A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy
SN  - 0006-4971
PY  - 1993///1126
KW  - Adult
KW  - Aged
KW  - Animals
KW  - Antibodies, Anti-Idiotypic
KW  - blood
KW  - Antibodies, Monoclonal
KW  - therapeutic use
KW  - Antigens, CD
KW  - immunology
KW  - Antigens, Differentiation, B-Lymphocyte
KW  - Blood Cells
KW  - drug effects
KW  - Cell Adhesion Molecules
KW  - Female
KW  - Humans
KW  - Immunotoxins
KW  - adverse effects
KW  - Lectins
KW  - Lymphoma, B-Cell
KW  - therapy
KW  - Male
KW  - Mice
KW  - Middle Aged
KW  - Ricin
KW  - Sialic Acid Binding Ig-like Lectin 2
KW  - Vascular Diseases
KW  - etiology
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
ER  -